Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
The Journal of Antimicrobial Chemotherapy
|
January 17, 2019
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria
Mike Marvin Ruth, Jasper J N Sangen, Karlijn Remmers, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2019
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models
Mike M Ruth, Gesham Magombedze, Tawanda Gumbo, et al.
The European Respiratory Journal
|
April 20, 2019
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary <i>Mycobacterium avium</i> complex disease
Sanne M H Zweijpfenning, Jodie A Schildkraut, Jordy P M Coolen, et al.
Journal of the American College of Emergency Physicians Open
|
May 10, 2021
Assessing COVID-19 pneumonia-Clinical extension and risk with point-of-care ultrasound: A multicenter, prospective, observational study
Arthur W E Lieveld, Bram Kok, Kaoutar Azijli, et al.
Plos One
|
March 26, 2021
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis
Gerine Nijman, Maike Wientjes, Jordache Ramjith, et al.
The European Respiratory Journal
|
November 9, 2016
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly
Richard van Altena, Onno W Akkerman, Jan-Willem C Alffenaar, et al.
Antimicrobial Agents and Chemotherapy
|
October 11, 2021
RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus
Jodie A Schildkraut, Jordy P M Coolen, Sophie Burbaud, et al.
Chest
|
January 22, 2022
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
Sanne Maria Henriette Zweijpfenning, Raphael Chiron, Sharon Essink, et al.
Chest
|
April 22, 2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
David E Griffith, Rachel Thomson, Patrick A Flume, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
March 16, 2021
A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury
Menso J Westerouen van Meeteren, Frederik Ma Van den Heuvel, Gert Weijers, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
The Journal of Antimicrobial Chemotherapy
|
January 17, 2019
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria
Mike Marvin Ruth, Jasper J N Sangen, Karlijn Remmers, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2019
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models
Mike M Ruth, Gesham Magombedze, Tawanda Gumbo, et al.
The European Respiratory Journal
|
April 20, 2019
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary <i>Mycobacterium avium</i> complex disease
Sanne M H Zweijpfenning, Jodie A Schildkraut, Jordy P M Coolen, et al.
Journal of the American College of Emergency Physicians Open
|
May 10, 2021
Assessing COVID-19 pneumonia-Clinical extension and risk with point-of-care ultrasound: A multicenter, prospective, observational study
Arthur W E Lieveld, Bram Kok, Kaoutar Azijli, et al.
Plos One
|
March 26, 2021
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis
Gerine Nijman, Maike Wientjes, Jordache Ramjith, et al.
The European Respiratory Journal
|
November 9, 2016
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly
Richard van Altena, Onno W Akkerman, Jan-Willem C Alffenaar, et al.
Antimicrobial Agents and Chemotherapy
|
October 11, 2021
RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus
Jodie A Schildkraut, Jordy P M Coolen, Sophie Burbaud, et al.
Chest
|
January 22, 2022
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
Sanne Maria Henriette Zweijpfenning, Raphael Chiron, Sharon Essink, et al.
Chest
|
April 22, 2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
David E Griffith, Rachel Thomson, Patrick A Flume, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
March 16, 2021
A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury
Menso J Westerouen van Meeteren, Frederik Ma Van den Heuvel, Gert Weijers, et al.
Page
of 8